Beryl Drugs Ltd. Share Price & Stock Analysis

Beryl Drugs Ltd. (BSE: 524606) is an Indore, Madhya Pradesh-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹12 Cr, it ranks #4,696 by market cap among the 6,197 Indian listed companies on FinBizNet, and #25 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹25.00 (as of 16 Nov 2026), the share price is 16.4% below its 52-week high of ₹29.90 and 57.0% above its 52-week low of ₹15.92. The share price is up 5.0% over one year and up 4.7% over three months.

Key Metrics

Current Price₹25.00
Market Cap₹12 Cr
BSE Code524606
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio28.7
Return on Equity4.38%
Return on Assets3.69%
52-Week Range₹15.92 – ₹29.90
1-Year Price Change+5.0%
3-Month Price Change+4.7%
Beta (1Y)0.33
HeadquartersIndore, Madhya Pradesh
Websitewww.beryldrugs.com

Shareholding and Delivery

Delivery averaged 85.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Beryl Drugs Ltd.

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

Products and Services

1. Pharmaceutical Industry-This segment manufactures and markets generic pharmaceutical formulations in India. 2. Trading Division-This segment engages in the sale and export of branded, generic pharmaceutical formulations in India. 3. Manufacturing Division-This segment engages in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India.

Business Segments

1. Pharmaceutical Industry-100%

Beryl Drugs Ltd. vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Beryl Drugs Ltd.₹12 Cr28.74.38%—+5.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Beryl Drugs Ltd.?

Beryl Drugs Ltd. is trading at ₹25.00, with a market capitalisation of ₹12 Cr.

Which sector does Beryl Drugs Ltd. belong to?

Beryl Drugs Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Beryl Drugs Ltd.?

Beryl Drugs Ltd. has a P/E of 28.7 and a return on equity of 4.38%.

What is the stock symbol of Beryl Drugs Ltd.?

Beryl Drugs Ltd. is listed on the BSE under the scrip code 524606.

How has Beryl Drugs Ltd.'s share price moved over the past year?

Beryl Drugs Ltd.'s share price is up 5.0% over one year and up 4.7% over three months. Its 52-week range is ₹15.92 to ₹29.90.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.